• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors.高岭土和氯仿激活纤溶酶原的复杂机制研究:哈格曼因子及其他辅助因子的作用
J Clin Invest. 1969 Oct;48(10):1786-801. doi: 10.1172/JCI106145.
2
The role of HF cofactor in the Hageman factor-dependent fibrinolytic mechanism.HF辅因子在接触因子依赖性纤溶机制中的作用。
Acta Haematol. 1981;66(4):257-63. doi: 10.1159/000207131.
3
The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator.人血浆的纤维蛋白溶解途径。纤溶酶原激活剂的分离与特性鉴定。
J Exp Med. 1972 Dec 1;136(6):1378-93. doi: 10.1084/jem.136.6.1378.
4
Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen.哈格曼因子依赖性纤维蛋白溶解:人活化因子XI与纤溶酶原相互作用产生纤维蛋白溶解活性。
Blood. 1979 Oct;54(4):850-62.
5
Chloroform-induced fibrinolysis. Its dependence on Hageman factor, plasma prekallikrein, and high molecular weight kininogen.氯仿诱导的纤维蛋白溶解。其对哈格曼因子、血浆前激肽释放酶和高分子量激肽原的依赖性。
J Lab Clin Med. 1980 Apr;95(4):507-14.
6
Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.弗莱彻因子缺乏症。由于缺乏前激肽释放酶导致哈格曼因子激活速率降低,伴有凝血、纤维蛋白溶解、趋化活性和激肽生成异常。
J Clin Invest. 1974 Feb;53(2):622-33. doi: 10.1172/JCI107597.
7
The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.哈格曼因子(因子 XII)及哈格曼因子片段对纤溶酶原的激活作用。
J Clin Invest. 1978 Jul;62(1):54-60. doi: 10.1172/JCI109113.
8
Studies on the participation of Hageman factor in fibrinolysis.关于哈格曼因子在纤维蛋白溶解中作用的研究。
Thromb Diath Haemorrh. 1970 Oct 31;24(1):1-9.
9
The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).人和兔血浆中激肽形成系统的首个成分。它与凝血因子XII(哈格曼因子)的关系。
J Exp Med. 1971 Oct 1;134(4):986-1004. doi: 10.1084/jem.134.4.986.
10
Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.哈格曼因子底物。人血浆前激肽释放酶:哈格曼因子的激活机制及参与哈格曼因子依赖性纤维蛋白溶解作用。
J Biol Chem. 1977 Sep 10;252(17):6097-104.

引用本文的文献

1
Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy.高纤溶、生理性纤溶和纤溶关闭:损伤后纤溶的范围及其与抗纤溶治疗的相关性。
J Trauma Acute Care Surg. 2014 Dec;77(6):811-7; discussion 817. doi: 10.1097/TA.0000000000000341.
2
Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil).菲茨杰拉德特质:凝血、纤维蛋白溶解、激肽生成的表面介导反应以及稀释血浆增强血管通透性(PF/Dil)的 hitherto 尚未被识别的因子、菲茨杰拉德因子的缺乏。
J Clin Invest. 1975 May;55(5):1082-9. doi: 10.1172/JCI108009.
3
Induction of proteolytic activity in serum by treatment with anionic detergents and organic solvents.用阴离子洗涤剂和有机溶剂处理诱导血清中的蛋白水解活性。
Experientia. 1983 Oct 15;39(10):1109-11. doi: 10.1007/BF01943134.
4
Haemostasis and the uterus.止血与子宫。
Br Med J. 1970 Jun 6;2(5709):553-4.
5
Coagulation and fibrinolysis after injury.损伤后的凝血与纤溶。
J Clin Pathol Suppl (R Coll Pathol). 1970;4:102-9. doi: 10.1136/jcp.s3-4.1.102.
6
Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.血浆α2-巨球蛋白(激肽释放酶抑制剂)对血浆凝血活酶前体与激肽释放酶的分离作用
J Clin Invest. 1971 Oct;50(10):2084-90. doi: 10.1172/JCI106702.
7
Clinical experience with brinase.布瑞纳酶的临床经验。
J Clin Pathol. 1972 Jul;25(7):654-5. doi: 10.1136/jcp.25.7.654.
8
A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.激肽释放酶原的一种前清蛋白激活剂。3. 人激肽释放酶原转化为激肽释放酶后出现对人中性粒细胞的趋化活性。
J Exp Med. 1972 Jan;135(1):81-97. doi: 10.1084/jem.135.1.81.
9
Prekallikrein deficiency in man.人类前激肽释放酶缺乏症。
J Exp Med. 1973 Dec 1;138(6):1345-55. doi: 10.1084/jem.138.6.1345.
10
Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.C1抑制物对凝血因子片段激活凝血、纤维蛋白溶解和激肽生成的抑制作用。
J Clin Invest. 1973 Jun;52(6):1402-9. doi: 10.1172/JCI107313.

本文引用的文献

1
Kinin formation and fibrinolysis in human plasma.人血浆中的激肽形成与纤维蛋白溶解
J Physiol. 1963 May;166(3):514-29. doi: 10.1113/jphysiol.1963.sp007120.
2
Partial purification and properties of a proteolytic enzyme of human serum.人血清中一种蛋白水解酶的部分纯化及性质
J Biol Chem. 1949 Nov;181(1):431-48.
3
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
4
Studies on a proteolytic enzyme system of the blood. Activation of profibrinolysin by serum fibrinolysokinase.血液中蛋白水解酶系统的研究。血清纤维蛋白溶激酶对纤维蛋白溶酶原的激活作用。
Proc Soc Exp Biol Med. 1951 Oct;78(1):184-8. doi: 10.3181/00379727-78-19014.
5
Changes in fibrinolytic activity produced by physical activity.体育活动所产生的纤溶活性变化。
Lancet. 1961 Sep 30;2(7205):730-3. doi: 10.1016/s0140-6736(61)90685-7.
6
Activation of endogenous plasma proteolytic enzymes with the consequent production of pharmacologically active polypeptides.内源性血浆蛋白水解酶的激活以及随之产生的具有药理活性的多肽。
Nature. 1962 Sep 22;195:1206-7. doi: 10.1038/1951206a0.
7
Proactivator function of human plasmin as shown by lysine esterase assay.通过赖氨酸酯酶测定显示的人纤溶酶的前激活剂功能。
J Biol Chem. 1961 Oct;236:2807-12.
8
Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system.活性哈格曼因子:人纤维蛋白溶解系统的一种血浆溶激酶。
J Clin Invest. 1962 Jun;41(6):1277-87. doi: 10.1172/JCI104590.
9
Studies on the thrombolytic activity of human plasma.人体血浆溶栓活性的研究。
J Clin Invest. 1960 Feb;39(2):426-34. doi: 10.1172/JCI104054.
10
[Role of the contact factor (Hageman factor) in fibrinolysis].[接触因子(哈格曼因子)在纤维蛋白溶解中的作用]
Thromb Diath Haemorrh. 1959 Sep 1;3:593-603.

高岭土和氯仿激活纤溶酶原的复杂机制研究:哈格曼因子及其他辅助因子的作用

Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors.

作者信息

Ogston D, Ogston C M, Ratnoff O D, Forbes C D

出版信息

J Clin Invest. 1969 Oct;48(10):1786-801. doi: 10.1172/JCI106145.

DOI:10.1172/JCI106145
PMID:4241814
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC322415/
Abstract

As demonstrated by others, fibrinolytic activity was generated in diluted, acidified normal plasma exposed to kaolin, a process requiring Hageman factor (Factor XII). Generation was impaired by adsorbing plasma with glass or similar agents under conditions which did not deplete its content of Hageman factor or plasminogen. The defect could be repaired by addition of a noneuglobulin fraction of plasma or an agent or agents eluted from diatomaceous earth which had been exposed to normal plasma. The restorative agent, tentatively called Hageman factor-cofactor, was partially purified by chromatography and had an apparent molecular weight of approximately 165,000. It could be distinguished from plasma thromboplastin antecedent (Factor XI) and plasma kallikrein, other substrates of Hageman factor, and from the streptokinase-activated pro-activator of plasminogen. Evidence is presented that an additional component may be needed for the generation of fibrinolytic activity in mixtures containing Hageman factor, HF-cofactor, and plasminogen.The long-recognized generation of plasmin activity in chloroform-treated euglobulin fractions of plasma was found to be dependent upon the presence of Hageman factor. Whether chloroform activation of plasminogen requires Hageman factor-cofactor was not determined, but glass-adsorbed plasma, containing Hageman factor and plasminogen, did not generate appreciable fibrinolytic or caseinolytic activity. These studies emphasize the complex nature of the mechanisms which lead to the generation of plasmin in human plasma.

摘要

正如其他人所证明的,在暴露于高岭土的稀释、酸化正常血浆中会产生纤溶活性,这一过程需要哈格曼因子(因子 XII)。在不消耗其哈格曼因子或纤溶酶原含量的条件下,用玻璃或类似试剂吸附血浆会损害纤溶活性的产生。通过添加血浆的非优球蛋白部分或从暴露于正常血浆的硅藻土中洗脱的一种或多种试剂,可以修复该缺陷。这种暂称为哈格曼因子辅因子的修复剂通过色谱法进行了部分纯化,其表观分子量约为 165,000。它可以与血浆凝血活酶前体(因子 XI)、血浆激肽释放酶(哈格曼因子的其他底物)以及链激酶激活的纤溶酶原激活剂区分开来。有证据表明,在含有哈格曼因子、HF 辅因子和纤溶酶原的混合物中,产生纤溶活性可能还需要一种额外的成分。长期以来人们认识到,血浆经氯仿处理的优球蛋白部分中纤溶酶活性的产生依赖于哈格曼因子的存在。氯仿激活纤溶酶原是否需要哈格曼因子辅因子尚未确定,但含有哈格曼因子和纤溶酶原的玻璃吸附血浆不会产生明显的纤溶或酪蛋白溶解活性。这些研究强调了导致人血浆中纤溶酶产生的机制的复杂性。